Improving the efficiency of purification in biopharmaceutical production

puridify.com

Sector

Therapeutics

Source

University College London

Investment stage

Series A

Puridify Ltd is a spin-out from the Advanced Centre of Biochemical Engineering at University College London. The company is developing a proprietary nanofibre technology to signficiantly improve productivity of purification in biopharmaceutical production (g/ml/min).

Puridify’s head office and research & development facilities are based at Stevenage Bioscience Catalyst, 20 minutes north of London.

Recent rapid evolution of the biopharmaceutical market has drawn focus to the limitations of current purification operations demanding a step-change improvement in processes.

Puridify’s technology, FibroSelect is a novel chromatography reagent, which enables productivity 50x greater than Protein A resins (>500 g/L/h) using a single cartridge on standard chromatography equipment.

Touchstone Innovations contact

Related news

View all news